Pharma R&D
Pharma R&D
Pharma R&D
Pharma R&D
INNOVATION
IN GENOMICS
GMDx Genomics (GMDx) is an Australian clinical diagnostic company that has developed an “AI enabled, true platform technology” delivering unprecedented genomic insights to:
Generate and track novel genomic profiles that provide a deep understanding of a person’s immune system health
Accurately predict cancer patient response to immunotherapy, and cancer progression
Deliver customized genomic profiles to accelerate
drug discovery and optimize all Phases (I-IV) of
the clinical trial process
Our executives explain the incredible work that has been achieved by GMDx and our dedicated team.
GMDx has multiple scientifically published, patented genomic discoveries to develop tests in cancer for treatment selection, disease progression and pharma development.
The GMDx enabling platform utilizes an industry-leading framework built on the Oracle Autonomous Cloud. The platform is readily accessible to GMDx partners globally. The Oracle partnership ensures compliance with all privacy and security requirements.